http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111557971-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51d89d90fb9ffd81e0ac449d16c8d8ab
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-533
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
filingDate 2020-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1f661c464c0a62245fc893d98670578
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afa37952b05b78db812c8c1a9c96aba1
publicationDate 2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111557971-A
titleOfInvention A kind of external medicine for treating hormone-dependent dermatitis and preparation method thereof
abstract The invention provides an external medicine for treating hormone-dependent dermatitis and a preparation method thereof. The extracted medicine and functional ingredients are dissolved in water to obtain a medicine aqueous solution; the medicine aqueous solution is adjusted to weak acidity to obtain a medicine stock solution; Concentrating the drug stock solution to 1.1-1.3g/mL under protection to obtain a drug concentrate; diluting the drug concentrate with water to 20 times the volume to obtain the external drug for treating hormone-dependent dermatitis. The preparation method of the topical medicine for the treatment of hormone-dependent dermatitis has higher abundance of active active ingredients and is more stable, and also has a reasonable pH value, is milder, and avoids further stimulation of the already sensitive hormone-dependent dermatitis patients. skin. Better experience.
priorityDate 2020-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458357694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536181

Total number of triples: 38.